Gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: A Phase II study

Cancer

Volumn 88, Issue 3, 2000, Pages 557-562

  Lilenbaum, Rogerio ^a   Cano, Roberto ^a   Schwartz, Michael ^a   Siegel, Leonard ^a   Lutzky, Jose ^a   Lewis, Mark ^a   Krill, Elisa ^a   Barreras, Luis ^a   Davila, Enrique ^a  

^a Miami Beach FL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; NAVELBINE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG TOLERABILITY; FEMALE; HUMAN; LUNG NON SMALL CELL CANCER; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; THROMBOCYTOPENIA; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS, PHYTOGENIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CONFIDENCE INTERVALS; DEOXYCYTIDINE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; NEUTROPENIA; PLEURAL EFFUSION, MALIGNANT; REMISSION INDUCTION; SURVIVAL RATE; THROMBOCYTOPENIA; VINBLASTINE;

EID: 0034141511     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(20000201)88:3<557::AID-CNCR10>3.0.CO;2-5     Document Type: Article

References (19)

1. Landis SH, Murray T, Bolden S, Wingo PA. Cancer statistics, 1998. CA Cancer J Clin 1998;48:6-48.
2. Ihde DC. Chemotherapy of lung cancer. N Engl J Med 1992; 327:1434-41.
3. Non-Small Cell Lung Cancer Collaborative Group. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials. Br J Med 1995;311:899-909.
4. Ramanathan RK, Belani CP. Chemotherapy for advanced non-small cell lung cancer: past, present, and future. Semin Oncol 1997;24:440-54.
5. LeChevalier T, Brisgand D, Douillard J-Y, Alberola V, Monnier A, Riviere A, et al. Randomized study of vinorelbine and cisplatin versus vindesine and cisplatin versus vinorelbine alone in advanced non-small cell lung cancer: results of a European multicenter trial including 612 patients. J Clin Oncol 1994;12:360-7.
6. Wozniak AJ, Crowley JJ, Balcerzak SP, Weiss GR, Laufman LR, Baker LH, et al. Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small cell lung cancer: a SouthWest Oncology Group study. - 1998;16:2459-65.
7. Sandler A, Nemunaitis J, Dehnam C, Cormier Y, von Pawel J, Niyikiza C, et al. Phase III study of cisplatin with or without gemcitabine in patients with advanced non-small cell lung cancer [abstract 1747]. Proc Am Soc Clin Oncol 1998;17:454a.
8. Rosell R, Tonato M, Sandler A. The activity of gemcitabine plus cisplatin in randomized trials in untreated patients with advanced non-small cell lung cancer. Semin Oncol 1998;25(Suppl 9):27-34.
9. Garst J, Crawford J, O'Rourke M, Herndon J, Traxler L, Burman S, et al. Vinorelbine and carboplatin for the treatment of patients with advanced non-small cell lung cancer: a phase II response, toxicity, and survival study [abstract 1223]. Proc Am Soc Clin Oncol 1996;15:404.
10. Ng EW, Sandler AB, Einhorn LH. A Phase II study of carboplatin plus gemcitabine in non-small cell lung cancer [abstract 1801]. Proc Am Soc Clin Oncol 1998;17:468a.
11. Rodier JM, Chouaki N, Schlumberger M, Ducreux M, Ruffie P, Rongier AM, et al. Gemcitabine and vinorelbine in solid tumors: preliminary results of a phase I study [abstract 881]. Proc Am Soc Clin Oncol 1997;16:249a.
12. Stephenson J, Aylesworth C, Johnson T, Atkins M, Rinaldi D, Burris H, et al. A phase I study of gemcitabine plus vinorelbine on an every other week schedule [abstract 970]. Proc Am Soc Clin Oncol 1998;17:253a.
13. Krajnik G, Mohn-Staudner A, Marhold F, Malayeri R, Zochbauer, Kummer F, et al. Vinorelbine/gemcitabine in advanced non-small cell lung cancer: a phase I trial [abstract 722]. Proc Am Soc Clin Oncol 1997;16:206a.
14. Herbst R, Dang N, Lynch C, Teicher B, Strauss G, Elias A, et al. Phase I study of combination weekly gemcitabine and vinorelbine in patients with lung cancer [abstract 1877]. Proc Am Soc Clin Oncol 1998;17:488a.
15. Johnson DH, Paul DM, Hande KR, DeVore RF. Paclitaxel and carboplatin in advanced non-small cell lung cancer: a phase II trial. J Clin Oncol 1996;14:2054-60.
16. Bunn PA. Denning the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions. Semin Oncol 1997;24(Suppl 12):153-62.
17. Treat J, Johnson E, Langer C, Belani C, Haynes B, Greenberg R, et al. Tirapazamine with cisplatin in patients with advanced non-small cell lung cancer: a phase II study. J Clin Oncol 1998;16:3524-7.
18. The Elderly Lung Cancer Vinorelbine Italian Study Group. Effects of vinorelbine on quality of life and survival of elderly patients with advanced non-small cell lung cancer. J Natl Cancer Inst 1999; 91:66-72.
19. Lorusso V, Mancarella S, Carpagnano F, Di Rienzo G, Cisternino L, Napoli G, et al. Gemcitabine plus vinorelbine in patients with stage IIIB-IV NSCLC: a phase II study [abstract 1808]. Proc Am Soc Clin Oncol 1998;17:470a.